Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs aimed toward increasing the horizons of cytokine-based immunotherapy, especially for cancers where treatment method selections remain limited. Use the links below to learn a lot more about our portfolio of cytokine-based immunotherapy candidates. Check https://financefeeds.com/ig-groups-q3-revenue-rises-to-268m-tastytrade-hits-record-trading/